+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Coronavirus Disease 2019 (COVID-19) Vaccines - Opportunity Assessment and Forecast to 2026

  • ID: 5360021
  • Report
  • June 2021
  • Region: Global
  • 73 pages
  • GlobalData

FEATURED COMPANIES

  • Arcturus
  • BioNTech
  • GlaxoSmithKline
  • Johnson & Johnson
  • Moderna
  • Pfizer
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

This report gives a COVID-19 disease overview, epidemiology overview, current marketed vaccines, unmet needs, pipeline assessment, and market outlook.

The publisher forecasts three different potential scenarios for the future use of COVID-19 vaccines:

  • The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
  • The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
  • In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.

Scope

This report includes:

  • Executive Summary
  • Disease Overview: History of the outbreak, Etiology and Pathophysiology
  • Epidemiology
  • Current Vaccination Options: Includes detailed product profiles with SWOT analysis
  • Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
  • Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
  • R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
  • Market Outlook

Reasons to Buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arcturus
  • BioNTech
  • GlaxoSmithKline
  • Johnson & Johnson
  • Moderna
  • Pfizer
  • MORE

1. Executive Summary

2. Disease Overview

3. Epidemiology

4. Current Vaccination Options

5. Unmet Needs and Opportunities

6. Pipeline Assessment

7. R&D Strategies

8. Market Outlook

9. Appendix

10. Contact the Publisher

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Pfizer
  • BioNTech
  • Moderna
  • AstraZeneca
  • Johnson & Johnson
  • Novavax
  • CureVac
  • Sanofi
  • GlaxoSmithKline
  • Arcturus
  • Medicago
  • Valneva
  • Inovio
Note: Product cover images may vary from those shown
Adroll
adroll